Histone deacetylases (HDACs) negatively regulate gene expression by removing acetyl groups from lysine residues present in histones and other proteins. Histone deacetylase 3 is unique among the Class I family of HDACs, as it is able to shuttle between the nucleus and the cytoplasm, whereas the other family members remain in the nucleus. Histone deacetylase 3 often forms complexes with corepressor proteins that do not associate with the other Class I HDACs, and its phosphorylation correlates with increased enzymatic activity. Here we show that HDAC3 also localizes to the plasma membrane in multiple cell types. Furthermore, c-Src is shown to form a complex with HDAC3 at the plasma membrane and to use HDAC3 as a substrate for phosphorylation. Our results describe a novel localization and binding partner for the HDAC3 protein, as well as implicate c-Src in HDAC3 regulation.
Histone deacetylases (HDACs) are global regulators of cellular transcription that function to deacetylate histones. Furthermore, HDACs regulate the function of other proteins including p53 and tubulin by deacetylation (Hubbert et al., 2002; Ito et al., 2002) . Class I HDACs are ubiquitously expressed and are active in complexes with other corepressor proteins. Among the four Class I HDACs, HDAC3 exhibits unique properties. Histone deacetylase 3 can shuttle in and out of the nucleus, whereas other Class I HDACs are found primarily in the nucleus (Yang et al., 2002) . Histone deacetylase 3 also forms complexes with cellular proteins such as SMRT/NcoR and MAPK11 that do not interact with other Class I HDACs (Guenther et al., 2000; Li et al., 2000) . Finally, HDAC3 is structurally distinct from other Class I HDACs, as its catalytic domain is positioned much closer to the C-terminus than other Class I HDACs (Yang et al., 2002) . This suggests that HDAC3 may possess unique binding partners and activity.
c-Src is a well-characterized cytoplasmic and membrane-associated tyrosine kinase that transduces mitogenic signals from a variety of growth factor receptors, leading to the activation of multiple phosphorylation signaling cascades. In addition to growth factor receptors, c-Src also associates with integrins as well as several other cellular proteins. This ultimately results in increased transcription and/or activity of proteins involved in cell growth and proliferation, cell motility and invasion (Brunton et al., 1997; Fleming et al., 1997; Owens et al., 2000) . Overexpression or aberrant regulation of c-Src has been detected in numerous cancers, and a related viral oncoprotein, v-Src, can transform cells (Jacobs and Rubsamen, 1983; Rosen et al., 1986; Fanning et al., 1992; MacMillan-Crow et al., 2000) . In cells, c-Src can be found in four different forms: (1) a non-phosphorylated form, which is usually only transient and not readily detected, (2) an inactive form in which Tyr527 is phosphorylated, (3) an active form in which Tyr416 is phosphorylated and (4) an inactive, transient form in which both Tyr527 and Tyr416 are phosphorylated (reviewed by Roskoski, 2004) . The protein is normally found in its inactive conformation in cells (Zheng et al., 2000) , but through autophosphorylation or phosphorylation by various kinases, a conformational change occurs and c-Src becomes active. Activated c-Src localizes to all areas of the cell and has also been shown to facilitate relocalization of proteins within the cell (Dib et al., 2003; Wrobel et al., 2004) . In addition, c-Src is one of only three Src family members to be expressed in most cell types, making it a key regulator of signal transduction via tyrosine phosphorylation.
In the course of studies to investigate if viral oncoproteins, such as human papillomavirus (HPV) E7, alter the cellular localization of HDACs, we detected a novel localization of HDAC3 to the plasma membrane. Histone deacetylase 1 and 2 were found exclusively in nuclei, and HPV proteins had no effect on their localization (Longworth et al., 2005) . Screening of HPV-positive (human foreskin keratinocyte (HFK) þ 31) and normal keratinocytes by immunofluorescence identified HDAC3 to be distributed diffusely throughout the nuclei, whereas a subpopulation was found localized at the plasma membrane in a punctate pattern (Figure 1a ). Similar patterns of HDAC3 localization to the plasma membranes were observed in mouse fibroblasts (Figure 1a) , the human osteosarcoma line, U2OS, and another cervical cancer derived cell line, CIN612 (data not shown). Human papillomavirus proteins did not alter the localization of HDAC3 proteins at the plasma membrane.
To ensure that the localization of HDAC3 to the plasma membrane was not an artifact due to the specific antibody used, we performed immunofluorescence analyses of HFK þ 31 cells as well as J2 mouse fibroblasts with two additional primary antibodies from different manufacturers. As shown in Figure 1b and c, similar punctate immunofluorescence patterns at membranes were observed using both antibodies. Interestingly, the dot-like structures detected by all three antibodies were only detected at areas of cell-cell contact. The structures were also of different sizes, which may be a result of HDAC3's ability to associate into multimeric structures (Yang et al., 2002) . To further confirm the membrane localization of HDAC3, HFK þ 31 cells were transiently transfected with an AU1-tagged HDAC3 expression plasmid and screened by immunofluorescence using an antibody to AU1. As shown in Figure 1d , cells transfected with a control AU1 tag construct exhibited a diffuse cytoplasmic and nuclear staining pattern ( Figure 1d ). In contrast, cells transfected with the AU1-HDAC3 construct exhibited punctate patterns of immunofluorescence at the cell periphery and diffuse staining in the nucleus, as detected by the AU1 antibody. This further demonstrates that HDAC3 is localized to the plasma membrane.
It was next important to investigate the nature of the interaction of HDAC3 at the plasma membrane. For these analyses, membrane and nuclear/cytoplasmic fractions were isolated by differential centrifugation in the presence of detergents and then examined by Western blot analysis for the presence of HDAC3. As shown in Figure 1e , HDAC3 was detected in both nuclear/cytoplasmic and membrane fractions. To investigate if HDAC3 was directly inserted into the plasma membrane or bound through complex formation with integral membrane proteins, cells were treated with a crosslinking agent before membrane isolation. After normalizing for nuclear material contamination, the addition of a crosslinking agent was found to increase the amount of HDAC3 in the membrane fractions by twofold. This observation was consistent with HDAC3 being bound to an integral membrane protein. The same samples were also screened by Western analysis for activated (EGFR) and Rb as controls for the effectiveness of the separation of membranes and nuclear/ cytoplasmic fraction. As expected, the EGFR proteins were found primarily in membrane fractions whereas Rb was localized primarily to the nuclear samples (Figure 1e ). Histone deacetylase 3 encodes a nuclear export signal that acts through the CRM-1 pathway. To investigate if the membrane-bound forms of HDAC3 shuttle between the nucleus, cells were treated with leptomycin-B and screened by immunofluorescence for loss of membrane-bound forms. Whereas control proteins were observed to be sequestered to the nucleus, no change in membrane-localized HDAC3 was found (Figure 1f ). This indicates that membrane-bound forms of HDAC3 are not dependent upon CRM-1-mediated export from the nucleus.
As our initial analyses indicated that HDAC3 was present at the plasma membrane through association with an integral membrane protein, we sought to identify the HDAC3 binding partner responsible through a series of colocalization studies. Using a variety of antibodies to known membrane proteins together with those for HDAC3, we screened for colocalization. Epidermal growth factor receptor, plakoglobin, desmoglein, plakophilin, E-cadherin, a-catenin and b-catenin all failed to colocalize with HDAC3 (data not shown). In contrast, immunostaining with an antibody to c-Src demonstrated a significant overlap in staining patterns with HDAC3 ( Figure 2a) . However, not all c-Src associated with HDAC3. In order to confirm that HDAC3 and c-Src formed a complex, co-immunoprecipitation studies were performed using antibodies to the inactive form of c-Src (Src-p527), the active form (Src-p416) or antibodies that recognize both forms (Src-S.C.). Src complexes were immunoprecipitated from membrane fractions of HFK þ 31 cells and screened by Western blot analysis for the presence of HDAC3. As shown in Figure 2b , HDAC3 was present in immunoprecipitations with all three Src antibodies but not in the IgG control. Interestingly, HDAC3 also precipitated with c-Src proteins found in nuclear/ cytoplasmic fractions as well ( Figure 2c) .
As c-Src can phosphorylate its binding partners, we next investigated if membrane-bound HDAC3 was modified by c-Src. For these studies, we isolated membrane fractions from cells, immunoprecipitated HDAC3 from these fractions and screened by Western blot analysis with antibodies to phosphorylated tyrosines. The methods for separation and controls for fractionation were the same as those used in the studies described in Figure 1 . As shown in Figure 3a , a significant fraction of membrane-associated HDAC3 was found to be phosphorylated at tyrosines. To determine if this phosphorylation was the result of c-Src activity, we treated cells before isolation of membrane fractions with protein phosphatase I (PP1), a specific inhibitor of c-Src, and screened for levels of tyrosine phosphorylation (Figure 3a) . The amount of HDAC3 protein localized to the membrane fraction did not change upon treatment with PP1; however, the levels of HDAC3 phosphorylated tyrosine residues were significantly reduced in the presence of the inhibitor (Figure 3a) . This suggests that membrane-associated HDAC3 is a substrate of c-Src; however, phosphorylation by c-Src does not appear to modulate the ability of HDAC3 to localize to membranes. We also investigated if the HDAC3 present in nuclear/cytoplasmic fractions was a substrate of c-Src. Using the analyses described above, we found that nuclear/cytoplasmic HDAC3 was indeed phosphorylated at tyrosines; however, treatment with PP1 had no effect on the levels of phosphorylation Figure 1 Histone deacetylase 3 (HDAC3) localizes to the plasma membrane of cells, independent of the CRM-1 pathway. (a) Histone deacetylase 3 forms punctate dot-like structures at the periphery of normal human foreskin keratinocytes (HFKs), HFKs containing copies of the human papillomavirus (HPV) 31 genome (HFK þ 31) and in J2 mouse fibroblasts. Cell cultures were maintained in Emedium, grown on coverslips and examined for HDAC3 localization by immunofluorescence as described previously (Fehrmann et al., 2003; Fehrmann and Laimins, 2004) (Invitrogen, Carlsbad, CA, USA) were analysed for immunofluorescence with the AU1 antibody from Covance (Berkeley, CA, USA) Cell nuclei were visualized through 4,6-diamidino-2-phenylindole (DAPI) staining. (e) Western blot analysis, performed as described by Longworth and Laimins (2004) , detected HDAC3 in HFK þ 31 nuclear fractions, uncrosslinked plasma membrane fractions and plasma membrane fractions from HFK þ 31 cells treated with 2 mM 3,3 0 -dithiobissulfosuccinimidylpropionate (Pierce Biotechnologies, Rockford, IL, USA) for 25 min at 41C. HFK þ 31 plasma membrane was isolated as described by Ellerbroek et al. (2001) . Western blot analyses using primary antibodies to Rb and to activated epidermal growth factor receptor (phospho-tyrosine 1045) were used as controls to monitor the effectiveness of membrane and nuclear/cytoplasmic fraction isolation. (f) Immunofluorescence analysis conducted using a primary antibody to (a) cyclin B1 (Santa Cruz, CA, USA) or (b) HDAC3 (Cell Signaling Technologies) demonstrated that leptomycin-B treatment of HFK þ 31 cells for 4 h at 371C inhibited the CRM-1-dependent export of cyclin B1 from the nucleus (top panel) but did not prevent HDAC3 localization to the plasma membrane (bottom panel). Vehicle (70% methanol)-treated and untreated cells were used as a control. Cell nuclei were visualized by DAPI staining. (Figure 3b ). This indicates that nuclear/cytoplasmic HDAC3 proteins are not substrates of c-Src in vivo but are the targets of other cellular tyrosine kinases.
We next investigated the ability of purified c-Src to phosphorylate HDAC3 in vitro. Histone deacetylase 3 proteins were immunoprecipitated from plasma membrane fractions as well as from nuclear/cytoplasmic fractions, incubated with purified c-Src and g 32 ATP in vitro. The reacted proteins were then analysed by SDSpolyacrylamide gel electrophoresis followed by autoradiography. Interestingly, the HDAC3 present in the plasma membrane fraction was not phosphorylated by purified c-Src in the in vitro assays, whereas HDAC3 isolated from the nuclear/cytoplasmic fraction was (Figure 3c ). c-Src did phosphorylate purified SAM68 protein, a known c-Src substrate but was unable to phosphorylate the IgG control (Figure 3c) (Fumagalli et al., 1994; Taylor and Shalloway, 1994) . Western blot analysis using a primary antibody to HDAC3 confirmed that equal amounts of HDAC3 were present in each of the reactions (Figure 3c, lower panel) . As the data in Figure 3a indicated that membrane-associated HDAC3 was phosphorylated by c-Src in vivo, we suspect that membrane-associated HDAC3 was already phosphorylated to saturation and therefore unable to be further modified. Furthermore, two c-Src family inhibitors, PP1 and PP2, were able to inhibit c-Src phosphorylation of HDAC3 immunoprecipitated from the cytoplasmic/ nuclear fraction of cells (Figure 3d ). Our observation that purified c-Src is able to phosphorylate nuclear/ cytoplasmic HDAC3 in vitro but does not do so in vivo suggests that additional factors may block the kinase activity in these cellular compartments. Overall, our data indicate that c-Src can phosphorylate HDAC3 and that this activity can be blocked by specific inhibitors. Finally, as HDAC3 is a deacetylase, we also investigated if c-Src was acetylated. Active and inactive forms of c-Src were immunoprecipitated from plasma membrane fractions of cells and analysed by Western blot analysis for acetylation using an antibody specific for acetylated lysines. Interestingly, although c-Src was found to be acetylated, treatment of cells with HDAC3 inhibitors did not alter the degree of acetylation (data not shown). We conclude that HDAC3 is a novel substrate for c-Src tyrosine kinase activity and that, in vivo, this occurs at the plasma membrane.
Our study describes a new localization for the HDAC3 protein and provides evidence of a novel protein association with the c-Src protein, which results in tyrosine phosphorylation. Recent studies have shown that phosphorylation of a specific serine residue in the HDAC3 protein is regulated by the kinase CK2 and by the phosphatase PP4, and that phosphorylation increases HDAC3 activity (Zhang et al., 2005) . It is therefore possible that tyrosine phosphorylation by c-Src may also regulate HDAC3 activity. Interestingly, c-Src phosphorylation of Yes-associated protein causes it to repress transactivation by the transcription factor Runx2, which regulates osteoblast differentiation (Zaidi et al., 2004) . Histone deacetylase 3 was recently shown to associate with Runx2 and to also be involved in bone formation (Schroeder et al., 2004) , suggesting that complex formation with c-Src and/or phosphorylation of HDAC3 may be an additional mechanism by which c-Src influences Runx2 transactivation. Although we are unsure of the targets of HDAC3 action at the membrane, we suspect that HDAC3 acts to regulate the function of target proteins at this location to regulate their activity. Our studies have identified a novel interaction of a Class I HDAC with c-Src at the plasma membrane and suggest that activities for HDACs extend beyond the nucleus. (2004) . A 10 mg portion of immunoprecipitated protein was used in each reaction and 2 mg of purified SAM68 (Santa Cruz Biotechnology) was used as a positive control reaction. Half of the samples were loaded onto a 10% SDS polyacrylamide gel, and electrophoresed, after which the gel was dried and bands were visualized by autoradiography. Remaining sample amounts were electrophoresed and analysed by Western blot analysis using the Cell Signaling HDAC3 antibody to measure loading of substrate protein (lower panel). (d) Histone deacetylase 3 proteins immunoprecipitated from the cytoplasmic/nuclear fraction of U2OS cells were analysed for the ability to be phopshorylated by c-Src kinase in vitro in the presence or absence of 0.3 mg of the c-Src inhibitors, PP1 or PP2. Assay and loading controls are identical to those described in (c).
